- Home
- INTS vs KRKR Comparison
INTS vs KRKR Comparison
Compare INTS & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- KRKR
- Stock Information
- Founded
- INTS 2012
- KRKR 2010
- Country
- INTS United States
- KRKR China
- Employees
- INTS N/A
- KRKR N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- KRKR Business Services
- Sector
- INTS Health Care
- KRKR Consumer Discretionary
- Exchange
- INTS Nasdaq
- KRKR Nasdaq
- Market Cap
- INTS 8.7M
- KRKR 8.5M
- IPO Year
- INTS 2023
- KRKR 2019
- Fundamental
- Price
- INTS $0.50
- KRKR $5.85
- Analyst Decision
- INTS Strong Buy
- KRKR
- Analyst Count
- INTS 3
- KRKR 0
- Target Price
- INTS $8.50
- KRKR N/A
- AVG Volume (30 Days)
- INTS 396.2K
- KRKR 15.3K
- Earning Date
- INTS 05-13-2025
- KRKR 03-11-2025
- Dividend Yield
- INTS N/A
- KRKR N/A
- EPS Growth
- INTS N/A
- KRKR N/A
- EPS
- INTS N/A
- KRKR N/A
- Revenue
- INTS N/A
- KRKR $31,657,328.00
- Revenue This Year
- INTS N/A
- KRKR $182.55
- Revenue Next Year
- INTS N/A
- KRKR N/A
- P/E Ratio
- INTS N/A
- KRKR N/A
- Revenue Growth
- INTS N/A
- KRKR N/A
- 52 Week Low
- INTS $0.50
- KRKR $2.76
- 52 Week High
- INTS $5.28
- KRKR $12.99
- Technical
- Relative Strength Index (RSI)
- INTS 18.57
- KRKR 74.32
- Support Level
- INTS $0.46
- KRKR $5.36
- Resistance Level
- INTS $0.59
- KRKR $6.00
- Average True Range (ATR)
- INTS 0.05
- KRKR 0.39
- MACD
- INTS 0.02
- KRKR 0.08
- Stochastic Oscillator
- INTS 21.14
- KRKR 91.85
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.